Clinical Trial Update: A Real-life Study to Learn About the Use and Effects of the CDK4/6 Inhibitors in Canadian Patients With Breast Cancer.

View source ↗

Summary

A real-world, Canadian observational study evaluating how CDK4/6 inhibitors are used and what effects they have in patients with breast cancer; results have bee…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Abemaciclib (abemaciclib)
• Palbociclib (palbociclib)
• Ribociclib (ribociclib)

Snippet

Sponsor: Pfizer | Conditions: Breast Cancer | Status: COMPLETED | Results posted: 2024-07-22